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Abstract
Background: In premature born infants red blood cell (RBC) transfusions have been associated with both
beneficial and detrimental sequels. Upon RBC transfusion, improvement in cerebral blood flow and oxygenation
have been observed, while a more liberal transfusion policy may be associated with a better developmental
outcome. The effect of the transfusion volume on long-term outcome is not known.
Methods: Observational follow-up study of a cohort of extremely premature born infants, treated in 2 neonatal
intensive care units using a different transfusion volume (15 ml/kg in Unit A and 20 ml/kg in Unit B). The primary
outcome was a composite of post discharge mortality, neuromotor developmental delay, blindness or deafness,
evaluated at a mean corrected age (CA) of 24 months related to the transfusion volume/kg bodyweight
administered during the postnatal hospital stay.
Results: Despite the difference in transfusion volume in clinically comparable groups of infants, they received a
similar number of transfusions (5.5 ± 3.2 versus 5.5 ± 2.3 respectively in Unit A and B). The total transfused volume
in unit A was 79 ± 47 ml/kg and 108 ± 47 ml/kg in unit B (p = 0.02). Total transfused RBC volume per kg
bodyweight was not an independent predictor of the composite outcome (p = 0.96, OR 1.0 (CI 0.9-1.1).
Conclusion: There was no relationship between the composite outcome at 24 months CA and transfusion volume
received during the post natal hospital stay. As there was no clinical advantage of the higher transfusion volume, a
more restrictive volume will reduce total transfusion volume and donor exposure. Future research on the optimal
transfusion volume per event to extreme preterm infants should include larger, prospective studies with a longer
follow-up period through to childhood or even adolescence.
Background
There is ongoing uncertainty whether transfusion of red
blood cells (RBC) in the neonatal period influences the
clinical outcome and development of premature infants.
In the international literature there is discussion about
the optimal transfusion volume and trigger [1].
We previously published a study comparing two trans-
fusion dosages of the same RBC product in two Dutch
tertiary care neonatal units (NICUs) using the same
transfusion trigger protocols [2]. No difference in short-
term outcome and mortality was observed in extremely
and very preterm infants when a dose of 15 ml/kg had
been administered compared to a volume of 20 ml/kg
bodyweight.
Little is known about the long-term follow-up of
extremely premature infants after RBC transfusion. Only
a few randomized trials have been published on long-
term outcome in premature infants with difference in
transfusion practice [3,4]. However, these were studies
(the PINT trial and the Iowa trial) comparing liberal
and restrictive transfusion triggers, exposing the infants
in the restrictive group to the possible risks of a low
hemoglobin level [5,6]. In sequel to our study on short-
term outcome we also wanted to compare long-term
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infants treated with different transfusion volumes but
with otherwise comparable transfusion triggers and
transfusion products.
In our follow-up study we evaluated post discharge
mortality, neuromotor developmental outcome and dis-
abilities in a cohort of extremely premature born infants




In the Netherlands no ethical approval is required for
this type of research as no new intervention or treat-
ment is studied. All collected data were anonymous.
Study population
This is a follow-up study of a cohort of extremely pre-
mature infants born before 28 gestational weeks that
participated in a previous study on transfusion practice
and short-term outcome in two Dutch NICUs. All
infants were transfused using the same transfusion trig-
gers and with a similar RBC blood product with only a
different volume per event, i.e. 15 and 20 ml/kg body-
weight. The study design was previously described [2].
The primary outcome measure was a composite of post
discharge mortality, neuromotor developmental outcome
and disabilities.
Transfusion guideline and product
All infants were transfused according to the Dutch con-
sensus for blood transfusion 2004 [7]. The recom-
mended transfusion triggers vary with postnatal age,
degree of illness and need for respiratory support:
- Hb <8 mmol/l (13 g/dl) (hematocrit (Hct) range
0.38-0.40 l/l) capillary (or <7 mmol/l arterial (11 g/dl)
(Hct 0.32-0.35 l/l)): the first 24 hours after birth in all
infants with clinical symptoms of anemia (tachycardia,
supplemental oxygen need, apnoea, bradycardia); in all
infants on mechanical ventilation or severely ill.
- Hb <7 mmol/l (12 g/dl) (Hct 0.32-0.35 l/l) capillary:
reasonably stable infants with cardio-respiratory pro-
blems (patent ductus arteriosus, apnoea, bronchopul-
monary dysplasia, need for supplemental oxygen).
- Hb <6 mmol/l (10 g/dl) (Hct 0.27-0.30 l/l) capillary:
stable premature infants with a postnatal age <4 weeks.
- Hb <4.5 mmol/l (7 g/dl) (Hct 0.2-0.23 l/l) capillary:
stable infants with a postnatal age >4 weeks if there are
no signs of anemia (apnoea, tachycardia, poor weight
gain, poor feeding). In case of symptomatic anemia,
transfusion is recommended at a higher threshold.
Transfusion volume per kg bodyweight was different
between the two hospitals; 15 ml/kg in Unit A and 20
ml/kg in Unit B. This transfusion volume was part of
the standard practice in the hospitals and was not cho-
sen for study purposes. The same transfusion product
was used in both hospitals. All products consisted of
pre-storage filtered RBC stored in additive solution Sal-
ine Adenine Glucose Mannitol (SAG-M) (maximum sto-
rage time 35 days), with a hematocrit of 0.58 ± 0.05 l/l.
The products were irradiated with 25 Gy less than 24
hours before transfusion.
Preventative measures for anemia of prematurity were
not standardised. Erythropoietin was not used in the
study units. Iron supplementation was started 6 to 8
weeks after birth if there had been no previous RBC
transfusion. After RBC transfusion iron supplementation
was postponed for four weeks because of the assumed
iron load given with the transfusion.
Data collection and outcome parameters
Infants with a syndrome or congenital/hereditary anom-
aly known to cause a neuromotor developmental delay
were excluded from analysis. Data on neuromotor devel-
opmental outcome, major disabilities (deafness, blind-
ness) and survival at a mean (± SD) corrected age (CA)
of 24 ± 3.4 months were obtained from each child’s out-
patient follow-up physician, child-psychologist and/or
pediatric physiotherapist, who were all trained in neona-
tal follow-up. Developmental examination was done in
different hospitals. The children were assessed with var-
ious instruments depending on the hospital of follow-
up. Instruments used were the Dutch 2
nd version of the
Bayley Scales of Infant Development-II (BSID-II-NL) [8],
the Griffiths Mental Development Scales [9], Alberta
Infant Motor Scale (AIMS) [10], and the Hempel [11],
Touwen [12], and van Wiechen [13] assessments of neu-
romotor development. The children were classified as
normal, mildly delayed or severely delayed, using the
cut-off values of each test, classifying severe neuromotor
developmental delay as a score of more than 2 SD
below average and mild neuromotor developmental
delay as a score 1 to 2 SD below the mean. Non-coop-
erative children received a general assessment by the
physician, pediatric physiotherapist and/or child-psy-
chologist. A parental questionnaire was sent to the par-
ents of the children if follow-up at age 2 years was
unknown by any of the previously mentioned
professionals.
Our primary outcome was the composite of post dis-
charge mortality, severe hearing or visual impairment,
or neuromotor developmental delay at 24 months CA.
Visual impairment was defined as <20/200 of best eye,
hearing impairment was defined as the need for a hear-
ing aid or cochlear implant. Neuromotor developmental
delay was defined as a score more than 1 SD below the
mean. The definition for bronchopulmonary dysplasia
(National Institutes of health Consensus, USA) was used
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prematurity the revised international classification was
used [15]. Intraventricular hemorrhage was graded
according to Volpe [16].
Statistical Analysis
All variables were analyzed by univariate analysis for
continuous variables and Chi-Square or Fishers exact
probability test for nominal variables. Backward step
wise logistic regression analysis was used for the inde-
pendent effect of the following factors: hospital (repre-
senting transfusion dose and unknown factors), number
of RBC transfusions, total transfused RBC volume per
kg bodyweight, gender, gestational age, birth weight,
CRIB II score and Apgar- score at 5 minutes. (SPSS 17
Chicago, United States of America). A p-value of less
than 0.05 was considered significant.
Results
Eighty-seven extremely premature infants were included
i no u re a r l i e rc o h o r ts t u d y( 4 4i nU n i tA ,4 3i nU n i tB ) .
Four infants died the first day of life and were excluded
from this follow-up study (1 lung hypoplasia, 1 massive
pulmonary hemorrhage, 1 severe perinatal asphyxia and
1 cause unknown). None of these children had received
a RBC transfusion. Twelve other patients died in the
neonatal period for various reasons; they had all
received RBC transfusions. They were also excluded
from follow-up. Seventy-one of the 87 infants (82%) left
the hospital alive (in total 9 in unit A and 7 in unit B
died (p = 0.78). There were no deaths after discharge
from the units. One other patient was excluded from
follow-up analysis because of a severe myopathy. Three
children were lost to follow-up in the first year of life;
one due to emigration, of the other two (twins) the rea-
son is unknown, leaving 67/70 (96%) of the eligible
infants surviving the post-natal period for neuromotor
developmental follow-up.
There were no statistically significant differences
when comparing the baseline characteristics of the
patients from both units (Table 1). The number of
transfusions administered was similar, 5.5 ± 3.2 (Unit
A )v e r s u s5 . 5±2 . 3( U n i tB )r e s p e c t i v e l y .A st h e
volume per transfusion event per center differed, the
mean total volume transfused in unit A and B was sig-
nificantly different (79 ± 47 ml/kg versus 108 ± 47 ml/
kg (p = 0.02) respectively). Neuromotor development
was evaluated at a mean 24 ± 3.4 months CA. One
infant had a severe visual impairment and one child
had severe hearing loss. Forty-seven out of 67 (70.1%)
infants showed normal neuromotor development for
corrected age. Seventeen infants (25.4%) had a mild
developmental delay and three infants were severely
impaired (4.5%).
There was no statistically significant difference in the
transfused volume for the primary outcome (composite
of post discharge mortality, neuromotor developmental
delay, blindness or deafness) compared to children with
a normal outcome (105 ± 52 ml versus 90 ± 47 ml
respectively) (p = 0.96, OR 1.0 (0.9-1.1). In multivariate
analysis none of the tested variables reached statistical
significance for an independent association with the
composite outcome (Table 2).
Discussion
Transfusion of RBC has been associated with negative
and positive effects on clinical outcome. Our study
showed no significant differences between a smaller and
a larger transfusion volume regarding a composite out-
come of post discharge mortality, neuromotor develop-
mental outcome and disabilities at 2 years CA. This
would imply that a smaller transfusion volume rather
has advantages (generally limiting donor exposure and
costs), than negative effects on neuromotor developmen-
tal outcome. It is possible that no effects were seen
because the difference in transfusion volume per trans-
fusion event was not large enough. On the other hand,
the total transfusion volume/kg during the post natal
hospital stay was significantly different in the two
NICUs. Several studies associated RBC transfusion with
the development of retinopathy of prematurity [17-20]
and chronic lung disease [21-23]. It is hypothesized that
iron overload, caused by multiple RBC transfusions,
increases oxidative stress leading to free radical-induced
injury to the premature retina and developing lungs
[24,25]. However, anemia has been associated with nega-
tive effects as well and in particular the brain may be
susceptible to low hemoglobin levels. Bell et al, in a ran-
domized study, found a statistically significant higher
incidence in the number of infants with intracranial
hemorrhage grade IV or periventricular leukomalacia
when a restrictive transfusion threshold was applied as
compared to a more liberal threshold [5]. On the other
hand, neither Chen [24] nor Kirpalani (PINT trial) [6]
found a statistically significant difference in the occur-
rence of (severe) intracranial pathology. However, the
follow-up study by Whyte et al. of infants included in
the PINT trial, suggested that preterm infants treated
with a more liberal transfusion regime may have a better
developmental outcome [4]. The premature infants
included in this multicenter PINT trial were analyzed at
18-21 months CA with regard to mortality, cerebral
palsy, severe visual impairment, hearing-loss, a Bayley-
Mental Developmental Index (MDI) score <70, and a
composite of these variables. Although there was no sta-
tistically significant difference in composite outcome
(45% in the restrictive and 38% in the liberal group), the
difference in cognitive delay (MDI score <70)
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group. A post-hoc analysis with cognitive delay rede-
fined (MDI score more than 1SD below the age-standar-
dized mean) showed a significant difference favoring the
liberal threshold group. This suggests that premature
infants may benefit from a higher hemoglobin threshold
for transfusion [4]. In the study by Nopoulos et al. on
the brain structure of 12 year old children previously
enrolled in the Iowa trial by Bell and colleagues, only 44
of the 100 children participated [3]. The children who
were exposed to the liberal transfusion threshold
appeared to have a substantially smaller intracranial
volume compared to the children transfused according
to the restrictive guideline. Nopoulos mentions unpub-
lished data on long-term cognitive follow-up showing
(non-significant but) overall poorer outcome in the
group of liberal transfused children.
Another recent study has shown that RBC transfu-
sions increase cerebral oxygenation, thereby decreasing
the risk of tissue hypoxia [26]. Mercer et al. showed that
premature male infants after delayed cord clamping, had
a better developmental outcome at seven months CA
compared to infants after immediate cord clamping [27].
It is conceivable that upon transfusion of a larger
volume, an increase in cerebral flow and better oxygena-
tion can be obtained with a similar effect as described
by Mercer.
In transfusion guidelines, the range of recommended
RBC volume per kilogram bodyweight is rather wide,
10-20 ml/kg. Given the variation in hematocrit between
used RBC products, the guidelines result in a huge var-
iation in actually transfused RBC.
We observed no influence of transfused volume RBC
per kg bodyweight on a composite of impaired neuro-
motor development, post discharge mortality and deaf-
ness or blindness in extremely preterm born infants
evaluated at 24 months CA. This finding remained
unchanged after logistic regression analysis correcting
for other factors relevant for outcome.
The two Dutch NICUs participating in this study used
t h es a m et r a n s f u s i o ng u i d e l i n e, transfusion trigger and
transfusion product, which virtually excludes important
differences in degree of anemia between infants. Our
study has its limits being a retrospective, non-randomized
trial. The neuromotor development was assessed using
various different tests. In Unit B all children were assessed
by the same special educator who is also a pediatric phy-
siotherapist (ICvH) using the same test (BSID-II-NL) in
95% of the children. The children from Unit A were
assessed using various validated tests, performed in differ-
ent hospitals by different professionals. It may be an incen-
tive to perform a larger, prospective randomized
controlled trial, focusing not only on the transfusion trig-
ger but also on the total transfused RBC volume to recom-
mend an optimal transfusion trigger and dose.
Conclusion
A high total transfused volume of RBC per kg was not
correlated with the composite outcome of impaired neu-
romotor developmental outcome, post discharge mortal-
ity, blindness or deafness when analyzed at 24 ± 3.4
Table 1 Characteristics of patients per unit included in follow-up study
Total (n = 67) Unit A (n = 31) Unit B (n = 36) p-value
Male, n 61% (41) 74% (23) 50% (18) 0.05
Gestational age, weeks mean SD 26 6/7 ± 4/7 26 6/7 ± 4/7 26 6/7 ± 4/7 0.65
Birth weight, grams mean SD 900 ± 187 906 ± 178 895 ± 197 0.59
AS 5 minutes, median (IQR) 8 (7-9) 8 (7-9) 8 (7-9) 0.88
IVH ≥ grade 3 9% (6) 13% (4) 6% (2) 0.40
BPD≥ moderate 35% (23) 29% (9) 40% (14) 0.35
ROP ≥ grade 2 12% (8) 13%(4) 11% (4) 1.0
Total number of transfusions, mean SD 5.5 ± 2.7 5.5 ± 3.2 5.5 ± 2.3 0.98
ML/per kg RBC administered, mean SD 95 ± 49 79 ± 47 108 ± 47 0.02
Composite outcome 31% (21) 29% (9) 33% (12) 0.71
AS = Apgar score, IVH = intraventricular hemorrhage, BPD = bronchopulmonary dysplasia, ROP = retinopathy of prematurity, RBC = red blood cells, composite
outcome = post discharge mortality, impaired neuromotor development, deafness or blindness
Table 2 Predictors of the composite outcome of
neuromotor developmental delay, post-discharge
mortality, blindness or deafness
P-value OR CI of OR (95%)
Hospital 0.8 1.6 0.1-24.7
Number of RBC transfusions 1.0 1.0 0.2-4.8
ML/kg RBC transfused 1.0 1.0 0.9-1.1
Gender 0.2 0.4 0.0-1.6
Gestational age 0.8 1.0 0.9-1.1
Birth weight 0.4 1.0 1.0-1.0
CRIB II score 0.6 1.0 1.0-1.0
Apgar score 5 min 0.3 1.2 0.8-1.9
RBC = red blood cells
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sumed possible detrimental effects of RBC transfusions.
Recommendations
Due to differences in neonatal transfusion practice, con-
clusions on the effect of maintaining a higher Hb value
by the use of liberal transfusion triggers or a larger
volume of RBC per transfusion are not based on strong
evidence. A larger transfusion volume may not be asso-
ciated with deleterious effects, whereas a smaller trans-
fusion volume may limit donor exposure. Through
randomized clinical studies, the effect of more liberal or
restrictive triggers on long-term outcome can be stu-
died, as well as the combination with a low (10 ml/kg)
or high (20 ml/kg) transfusion volume. A longitudinal
study to school age or even adolescence looking for
instance at academic competencies might give further
insight in the effects of different transfusion volumes.
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